(Q46001389)

English

Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

author name string

Makoto Sugihara

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

Shin-Ichiro Miura

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

Yosuke Takamiya

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

Yoshihiro Kiya

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

Tadaaki Arimura

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

Atsushi Iwata

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

Akira Kawamura

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

Hiroaki Nishikawa

8

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

Yoshinari Uehara

9

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

Keijiro Saku

10

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

publication date

22 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

Hypertension Research

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

32

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

625-630

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

Molecular analysis of the structure and function of the angiotensin II type 1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

The J-curve in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Angiotensin receptor blockade decreases markers of vascular inflammation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Removing confounders from the relationship between mortality risk and systolic blood pressure at low and moderately increased systolic blood pressure.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

C-reactive protein (CRP)-lowering agents

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Pentraxin3 is a novel marker for stent-induced inflammation and neointimal thickening.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Randomized comparison of early inflammatory response after sirolimus-eluting stent vs bare metal stent implantation in native coronary lesions

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Changes in CCR2 chemokine receptor expression and plasma MCP-1 concentration after the implantation of bare metal stents versus sirolimus-eluting stents in patients with stable angina

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Comparison of the systemic levels of inflammatory markers after percutaneous coronary intervention with bare metal versus sirolimus-eluting stents.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporter.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Effect of the angiotensin II receptor antagonist valsartan on lipid profile and glucose metabolism in patients with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding properties

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

21 January 2018

Validity of the JNC VI recommendations for the management of hypertension in a general population of Japanese elderly: the Hisayama study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

7 January 2021

based on heuristic

inferred from DOI database lookup

Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

7 January 2021

based on heuristic

inferred from DOI database lookup

Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil in achieving 24-hour blood pressure reductions and ambulatory blood pressure goals

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.66

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/HR.2009.66

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19461652

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46001389&oldid=2207518780"